Laboratory Corporation of America ® Holdings (LabCorp ® )
(NYSE: LH) and Covance Inc. (NYSE: CVD) today announced that they have
entered into a definitive agreement under which LabCorp will acquire
Covance for cash and LabCorp shares currently valued at $105.12 per
Covance share, or an equity value of approximately $6.1 billion and an
enterprise value of approximately $5.6 billion.
for LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World’s Leading Healthcare Diagnostics Company investment picks